NEW YORK (GenomeWeb News) – Abbott's board of directors this week approved the separation of the firm's research-based pharmaceuticals business into a new company called AbbVie and declared a special dividend distribution for all of the outstanding shares of AbbVie common stock.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

In Nature this week: a Danish reference genome, and more.